Back
Akero Therapeutics, Inc. Stock Price Chart
Get Your Free Stock Selector Checklist and Invest Smarter
Get Your Free Safe Stock Selector Checklist Now
Buy
64
AKRO
Akero Therapeutics, Inc.
Last Price:
$54.66
Seasonality Move:
10.37%
7 Day Trial
ALL ACCESS PASS
$
7
Safe Investing Checklist - Stay Clear of Risky Stocks
Get Your Free Safe Stock Selector Checklist Now-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AKRO is experiencing slight buying pressure.
Akero Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 54.59 | Buy |
| 20-day SMA: | 54.42 | Buy |
| 50-day SMA: | 53.2 | Buy |
| 200-day SMA: | 48.26 | Buy |
| 8-day EMA: | 54.58 | Buy |
| 20-day EMA: | 54.34 | Buy |
| 50-day EMA: | 53.03 | Buy |
| 200-day EMA: | 47.61 | Buy |
Akero Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.4 | Buy |
| Relative Strength Index (14 RSI): | 69.15 | Buy |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (54.16 - 54.56) | Buy |
| Bollinger Bands (100): | (46.49 - 54.15) | Buy |
Akero Therapeutics, Inc. Technical Analysis
| Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 26 | 28 | 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Akero Therapeutics, Inc. Stock
Is Akero Therapeutics, Inc. Stock a Buy?
-
Akero Therapeutics, Inc. share price is 54.65 while AKRO 8-day simple moving average is 54.59, which is a Buy signal.
-
The stock price of AKRO is 54.65 while Akero Therapeutics, Inc. 20-day SMA is 54.42, which makes it a Buy.
-
Akero Therapeutics, Inc. 50-day simple moving average is 53.20 while AKRO share price is 54.65, making it a Buy technically.
-
AKRO stock price is 54.65 and Akero Therapeutics, Inc. 200-day simple moving average is 48.26, creating a Buy signal.
AKRO Technical Analysis vs Fundamental Analysis
Buy
64
Akero Therapeutics, Inc. (AKRO)
is a Buy
Is Akero Therapeutics, Inc. a Buy or a Sell?
-
Akero Therapeutics, Inc. stock is rated a BuyThe current Akero Therapeutics, Inc. [AKRO] share price is $54.65. The Score for AKRO is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
Akero Therapeutics, Inc. Stock Info
Market Cap:
4.5B
Price in USD:
54.65
Share Volume:
0
Akero Therapeutics, Inc. 52-Week Range
52-Week High:
58.40
52-Week Low:
21.34
Buy
64
Akero Therapeutics, Inc. (AKRO)
is a Buy
Akero Therapeutics, Inc. Share Price Forecast
-
What is the Akero Therapeutics, Inc. stock price today?The Akero Therapeutics, Inc. stock price is 54.65 USD today.
-
Will AKRO stock go up or go down?Akero Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Akero Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Akero Therapeutics, Inc. is not overvalued.
Is Akero Therapeutics, Inc. Stock a Buy?
-
Akero Therapeutics, Inc. share price is 54.65 while AKRO 8-day exponential moving average is 54.58, which is a Buy signal.
-
The stock price of AKRO is 54.65 while Akero Therapeutics, Inc. 20-day EMA is 54.34, which makes it a Buy.
-
Akero Therapeutics, Inc. 50-day exponential moving average is 53.03 while AKRO share price is 54.65, making it a Buy technically.
-
AKRO stock price is 54.65 and Akero Therapeutics, Inc. 200-day simple moving average is 47.61, creating a Buy signal.
Fundamental Analysis of Akero Therapeutics, Inc.
Is Akero Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.02 per share, and a decrease next year of $0.29 per share.
Technical Analysis of Akero Therapeutics, Inc.
Should I short Akero Therapeutics, Inc. stock?
-
AKRO Moving Average Covergence Divergence (MACD) indicator is 0.4, suggesting Akero Therapeutics, Inc. is a Buy
-
Akero Therapeutics, Inc. Relative Strength Index (RSI) is 69.15, which suggest Akero Therapeutics, Inc. is overbought
-
The Bollinger Bands (25) for Akero Therapeutics, Inc. is (54.16 - 54.56), which suggest Akero Therapeutics, Inc. is a Buy
-
The Bollinger Bands (100) for Akero Therapeutics, Inc. is (46.49 - 54.15), which suggest Akero Therapeutics, Inc. is a Buy
* Akero Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.